Terms: = Sarcomas AND FANCD2, FANCD, 2177, ENSG00000144554, FLJ23826, FAD, FACD, FA4, FA-D2, FAD2, DKFZp762A223 AND Treatment
10 results:
1. Clinicopathological Analysis and treatment of Adult Patients with Inflammatory Myofibroblastic Tumor: A 15-Year Single- Center Study.
Liu X; Gong C; Zhang J; Feng W; Guo Y; Sang Y; Wang C; Chen Y; Wang J; Yu L; Zhang X; Luo Z
Cancer Res Treat; 2023 Jul; 55(3):1001-1010. PubMed ID: 36915248
[TBL] [Abstract] [Full Text] [Related]
2. fancd2 inhibits ferroptosis by regulating the JAK2/STAT3 pathway in osteosarcoma.
Li X; Liu J
BMC Cancer; 2023 Feb; 23(1):179. PubMed ID: 36814203
[TBL] [Abstract] [Full Text] [Related]
3. Impaired Fanconi anemia pathway causes DNA hypomethylation in human angiosarcomas.
Zhu K; Sun S; Guo F; Gao L
Hum Cell; 2022 Sep; 35(5):1602-1611. PubMed ID: 35817884
[TBL] [Abstract] [Full Text] [Related]
4. Osteosarcoma cells with genetic signatures of BRCAness are susceptible to the PARP inhibitor talazoparib alone or in combination with chemotherapeutics.
Engert F; Kovac M; Baumhoer D; Nathrath M; Fulda S
Oncotarget; 2017 Jul; 8(30):48794-48806. PubMed ID: 27447864
[TBL] [Abstract] [Full Text] [Related]
5. First-Line Aldoxorubicin vs Doxorubicin in Metastatic or Locally Advanced Unresectable Soft-Tissue Sarcoma: A Phase 2b Randomized Clinical Trial.
Chawla SP; Papai Z; Mukhametshina G; Sankhala K; Vasylyev L; Fedenko A; Khamly K; Ganjoo K; Nagarkar R; Wieland S; Levitt DJ
JAMA Oncol; 2015 Dec; 1(9):1272-80. PubMed ID: 26378637
[TBL] [Abstract] [Full Text] [Related]
6. fancd2 is a potential therapeutic target and biomarker in alveolar rhabdomyosarcoma harboring the PAX3-FOXO1 fusion gene.
Singh M; Leasure JM; Chronowski C; Geier B; Bondra K; Duan W; Hensley LA; Villalona-Calero M; Li N; Vergis AM; Kurmasheva RT; Shen C; Woods G; Sebastian N; Fabian D; Kaplon R; Hammond S; Palanichamy K; Chakravarti A; Houghton PJ
Clin Cancer Res; 2014 Jul; 20(14):3884-95. PubMed ID: 24787670
[TBL] [Abstract] [Full Text] [Related]
7. Sensitivity and resistance to treatment in the primary management of epithelial ovarian cancer.
Colombo PE; Fabbro M; Theillet C; Bibeau F; Rouanet P; Ray-Coquard I
Crit Rev Oncol Hematol; 2014 Feb; 89(2):207-16. PubMed ID: 24071502
[TBL] [Abstract] [Full Text] [Related]
8. Use of self-expanding vascular endoprostheses in superior vena cava syndrome.
García Mónaco R; Bertoni H; Pallota G; Lastiri R; Varela M; Beveraggi EM; Vassallo BC
Eur J Cardiothorac Surg; 2003 Aug; 24(2):208-11. PubMed ID: 12895609
[TBL] [Abstract] [Full Text] [Related]
9. [Poor prognosis of osteosarcoma of pelvis; 39 years of registration by the Netherlands Commission on Bone Tumors].
Ham SJ; Kroon HM; Schraffordt Koops H; Hoekstra HJ
Ned Tijdschr Geneeskd; 2000 Jan; 144(3):121-5. PubMed ID: 10674118
[TBL] [Abstract] [Full Text] [Related]
10. Thermoradiotherapy for superficial tumour deposits in the head and neck.
Engin K; Tupchong L; Waterman FM; Cater JR; Koppel A; Dietz D; Hoh L; McFarlane JD; Leeper DB
Int J Hyperthermia; 1994; 10(2):153-64. PubMed ID: 8064177
[TBL] [Abstract] [Full Text] [Related]